Table 2 Structural refinement statistics of the CRBN TBD bound to thalidomides.
From: Structural basis of thalidomide enantiomer binding to cereblon
 | (S)-thalidomide | (R)-thalidomide | (RS)-thalidomide (racemic) |
---|---|---|---|
Rwork/Rfreea (%) | 18.8/21.6 | 18.7/21.1 | 18.9/21.0 |
Number of atoms | 13,621 | 13,077 | 13,548 |
  CRBN molecules | 16 | 16 | 16 |
     residues | 1,505 | 1,500 | 1,505 |
  Thalidomide | 16 | 16 | 16 |
  Zinc ions | 16 | 16 | 16 |
  Sulphate ions | 30 | 30 | 30 |
  Water molecules | 1,313 | 809 | 1,240 |
Averaged B-factors (Ã…2) | |||
CRBN molecules | 27.8 | 32.4 | 27.6 |
  Thalidomide | 26.9 | 37.3 | 28.1 |
  Zinc ions | 27.8 | 27.7 | 24.8 |
  Sulphate ions | 43.9 | 46.6 | 42.8 |
  Water molecules | 40.9 | 42.2 | 40.9  |
R.m.s.d. from ideal values | |||
    bonds (Å) | 0.005 | 0.005 | 0.005 |
    angles (°) | 1.011 | 1.029 | 1.066 |
Ramachandran plots (%) | |||
    Favored | 98.8 | 98.8 | 98.7 |
    Allowed | 1.2 | 1.2 | 1.3 |
   Outliers | 0 | 0 | 0 |